Detalhe da pesquisa
1.
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study.
Lancet Oncol
; 23(12): 1558-1570, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400106
2.
BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors.
Future Oncol
; 18(29): 3245-3254, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950603
3.
An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.
Breast Cancer Res
; 23(1): 30, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33663560
4.
Lipid microsphere bound oxycodone for pain management in patients receiving radiotherapy for head and neck cancer.
Support Care Cancer
; 29(1): 263-269, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32350670
5.
Less Toxic Chemotherapy in Locally Advanced Breast Cancer.
South Med J
; 113(11): 559-563, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140109
6.
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(8): 977-1007, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390582
7.
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Breast Cancer Res Treat
; 171(3): 637-648, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938395
8.
First-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibition.
J Natl Compr Canc Netw
; 16(10): 1166-1170, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323086
9.
NCCN Guidelines Insights: Antiemesis, Version 2.2017.
J Natl Compr Canc Netw
; 15(7): 883-893, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687576
10.
Induction chemotherapy for head and neck cancer: is there still a role?
Future Oncol
; 12(13): 1595-608, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27093876
11.
Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
Hematol Oncol
; 33(4): 206-11, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24850172
12.
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007.
Breast Cancer Res Treat
; 148(1): 99-106, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25257727
13.
Assessment of erlotinib as adjuvant chemoprevention in high-risk head and neck cancer patients.
Ann Surg Oncol
; 21(13): 4263-9, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25001094
14.
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma.
Clin Cancer Res
; 30(1): 63-73, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861407
15.
Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer.
Cancer Med
; 12(3): 3488-3498, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979540
16.
Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 9(11): 1565-1573, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768670
17.
By the pricking of my thumbs, something wicked this way comes: sporadic cancers versus eponymous hereditary cancer predisposition syndromes.
J Natl Compr Canc Netw
; 10(1): 7-13, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22223865
18.
Chemotherapy-resistant metastatic breast cancer.
Curr Treat Options Oncol
; 13(2): 263-75, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22528367
19.
Racial and rural-urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort.
Head Neck
; 44(7): 1563-1575, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35396877
20.
Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patients.
Front Cardiovasc Med
; 9: 1024846, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36712282